Correction: Adaptive Reprogramming of De Novo Pyrimidine Synthesis Is a Metabolic Vulnerability in Triple-Negative Breast Cancer
- PMID: 28607097
- DOI: 10.1158/2159-8290.CD-17-0565
Correction: Adaptive Reprogramming of De Novo Pyrimidine Synthesis Is a Metabolic Vulnerability in Triple-Negative Breast Cancer
Erratum for
-
Adaptive Reprogramming of De Novo Pyrimidine Synthesis Is a Metabolic Vulnerability in Triple-Negative Breast Cancer.Cancer Discov. 2017 Apr;7(4):391-399. doi: 10.1158/2159-8290.CD-16-0611. Epub 2017 Mar 2. Cancer Discov. 2017. PMID: 28255083 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources